Stockscreener 앱 받기
4.626
2.63%
-0.124
전일 마감가:
$4.75
열려 있는:
$4.74
하루 거래량:
2.98M
Relative Volume:
0.42
시가총액:
$1.38B
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
-11.86
EPS:
-0.39
순현금흐름:
$-68.47M
1주 성능:
+1.65%
1개월 성능:
+162.78%
6개월 성능:
+159.83%
1년 성능:
+379.27%
1일 변동 폭
$4.49
$4.7605
1주일 범위
$4.41
$5.225
52주 변동 폭
$0.6513
$5.225
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.62 | 1.42B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.44 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.27 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.00 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
322.25 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Precigen Secures $125 Mln Credit Facility From Pharmakon To Advance PAPZIMEOS Commercialization - Nasdaq
Candlestick signals on Precigen Inc. stock todayWeekly Trend Summary & Community Consensus Stock Picks - Newser
Germantown's Precigen secures $125M loan to take first drug to market - The Business Journals
Precigen, Inc. announced that it expects to receive $125 million in funding - MarketScreener
Precigen announces up to $125M non-dilutive financing - MSN
Visual trend scoring systems applied to Precigen Inc.2025 Support & Resistance & Stock Market Timing Techniques - Newser
What earnings revisions data tells us about Precigen Inc.Quarterly Investment Review & Low Drawdown Momentum Ideas - Newser
Sector Update: Health Care - MarketScreener
BioPharma Credit to Invest $62.5 Million in US-based Precigen - MarketScreener
Precigen Signs Up to $125 Million Credit Facility Deal With Pharmakon Advisors - MarketScreener
News impact scoring models applied to Precigen Inc.Options Play & Risk Controlled Stock Pick Alerts - Newser
Precigen’s Non-Dilutive $125M Financing: A Strategic Inflection Point for Commercialization and Shareholder Value - AInvest
Precigen secures $100 million in non-dilutive financing - Investing.com
Precigen Secures $125M Loan for PAPZIMEOS Expansion - TipRanks
Precigen secures up to $125 million in senior secured loan financing - Investing.com
Will Precigen Inc. outperform the marketTrade Analysis Report & Daily Volume Surge Signals - Newser
$125M Non-Dilutive Deal: Precigen Secures Major Funding for Revolutionary HPV Immunotherapy Launch - Stock Titan
What makes Precigen Inc. stock price move sharplyJuly 2025 Review & Weekly High Potential Alerts - Newser
Precigen Inc. stock trendline breakdownJuly 2025 Reactions & Verified Swing Trading Watchlist - Newser
Is a relief rally coming for Precigen Inc. holdersEarnings Miss & Technical Entry and Exit Alerts - Newser
Should you wait for a breakout in Precigen Inc.Market Performance Report & Advanced Technical Signal Analysis - Newser
Building trade automation scripts for Precigen Inc.Dollar Strength & Verified Chart Pattern Trade Signals - Newser
How high can Precigen Inc. stock goJuly 2025 Volume & Risk Managed Investment Signals - Newser
Precigen, Inc. shares rise 1.68% after-hours following a special call with CEO and CCO. - AInvest
Tennant Company shares fall 1.46% intraday after Precigen, Inc. special call featuring CEO and CCO. - AInvest
Precigen upgraded to Neutral from Underweight at JPMorgan - MSN
Is Precigen Inc. stock bottoming outWeekly Market Outlook & Smart Investment Allocation Tips - Newser
Precigen stock hits 52-week high, reaching $4.83 - Investing.com
Precigen stock hits 52-week high, reaching $4.83 By Investing.com - Investing.com UK
Does Precigen Inc. fit your quant trading modelJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
What recovery options are there for Precigen Inc.Earnings Risk Report & Fast Entry High Yield Stock Tips - Newser
Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - MSN
Using portfolio simulators with Precigen Inc. includedEarnings Trend Report & Verified Short-Term Trading Plans - Newser
Is Precigen Inc. a play on infrastructure spendingMarket Sentiment Review & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Is Precigen Inc. a top pick in the sectorJuly 2025 Sentiment & Daily Profit Maximizing Tips - khodrobank.com
Precigen’s SWOT analysis: biotech stock poised for growth with RRP therapy - Investing.com
Will Precigen Inc. stock go up in YEARQuarterly Portfolio Summary & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
What Fibonacci levels say about Precigen Inc. reboundAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - Newser
Real time scanner hits for Precigen Inc. explainedMarket Movement Recap & AI Forecasted Entry and Exit Points - Newser
Precigen Inc. Stock Fails to Break Resistance Traders React getLinesFromResByArray error: size == 0 - kangso.co.kr
Multi factor analysis applied to Precigen Inc.2025 Analyst Calls & Verified Entry Point Detection - Newser
Developing predictive dashboards with Precigen Inc. data2025 Key Lessons & Detailed Earnings Play Alerts - Newser
Backtesting results for Precigen Inc. trading strategiesQuarterly Market Summary & AI Forecast for Swing Trade Picks - Newser
How to recover losses in Precigen Inc. stockJuly 2025 Drop Watch & Community Shared Stock Ideas - Newser
Precigen Inc. stock outlook for YEARInsider Selling & Weekly High Return Stock Opportunities - Newser
What recovery options are there for Precigen IncJuly 2025 Gainers & Growth Focused Entry Reports - Newser
Is Precigen Inc. stock a good hedge against inflationWeekly Market Outlook & Weekly Stock Performance Updates - Newser
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precigen Inc 주식 (PGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| AGEE NANCY H | Director |
Aug 19 '25 |
Buy |
3.20 |
15,360 |
49,152 |
192,196 |
| KIRK RANDAL J | Director |
Mar 14 '25 |
Option Exercise |
0.00 |
174,825 |
0 |
64,779,510 |
1.37%
0.35%
자본화:
|
볼륨(24시간):